Trial Profile
Clinical Trials Insight: 700031656
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 18 Mar 2008
Price :
$35
*
At a glance
- Drugs ENMD 1198 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors CASI Pharmaceuticals
- 18 Mar 2008 New trial record.